Ascendis Pharma A-S
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $35,998 | $35,998 | $95,894 | $48,034 |
Gross Profit | 24,533 | 24,533 | 88,325 | 40,646 |
EBITDA | -89,527 | -46,889 | -132,316 | |
EBIT | -93,937 | -51,392 | -137,196 | |
Net Income | -109,380 | -109,380 | -131,035 | -162,223 |
Net Change In Cash | 35,998 | 35,998 | 95,894 | 48,034 |
Free Cash Flow | -61,650 | -101,781 | -125,695 | |
Cash | 258,696 | 258,696 | 320,239 | 441,268 |
Basic Shares | 57,349 | 57,345 | 56,883 | 56,272 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $266,718 | $51,174 | $7,778 | $6,953 |
Gross Profit | 222,323 | 39,037 | 4,255 | 6,953 |
EBITDA | -438,168 | -556,040 | -423,668 | -328,884 |
EBIT | -457,079 | -573,674 | -439,672 | -337,686 |
Net Income | -481,447 | -583,194 | -383,577 | -418,955 |
Net Change In Cash | 266,718 | 51,174 | 7,778 | 6,953 |
Free Cash Flow | -469,803 | -510,188 | -441,883 | -293,100 |
Cash | 392,164 | 444,767 | 446,267 | 584,517 |
Basic Shares | 56,287 | 56,071 | 54,771 | 50,616 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.72 |
2024-06-30 | -$2.11 |
2024-03-31 | -$2.30 |
2023-12-31 | -$1.54 |
